Literature DB >> 9389342

Development of an assay for the simultaneous determination of sildenafil (Viagra) and its metabolite (UK-103,320) using automated sequential trace enrichment of dialysates and high-performance liquid chromatography.

J D Cooper1, D C Muirhead, J E Taylor, P R Baker.   

Abstract

The development of the ASTED (automated sequential trace enrichment of dialysates) system to prepare plasma samples prior to high-performance liquid chromatography (HPLC) of sildenafil and its demethylated metabolite (UK-103,320) is described. Investigations to elucidate potential pitfalls of the ASTED on-line sample preparation system prior to separation of the analytes by HPLC are presented. The procedure is shown to be selective for sildenafil and UK-103,320, and linear over the range 1.00-250 ng/ml. The intra-batch imprecision (C.V.) of the method at plasma analyte concentrations of 1.00, 5.00, 50.0 and 200 ng/ml was 11.2, 3.10, 1.50, and 1.30%, respectively, and the corresponding inter-batch imprecision was estimated to be 13.5, 7.09, 3.69, and 5.43%. At these plasma analyte concentrations the overall inaccuracy (% bias) of the procedure ranged from 3.6 to 8.4%. The method showed similar assay performance for the estimation of the metabolite, UK-103,320. The application of the assay to a pharmacokinetic investigation during a clinical study is presented.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9389342     DOI: 10.1016/s0378-4347(97)00339-3

Source DB:  PubMed          Journal:  J Chromatogr B Biomed Sci Appl        ISSN: 1387-2273


  13 in total

1.  Pharmacokinetic interactions between sildenafil and saquinavir/ritonavir.

Authors:  G J Muirhead; M B Wulff; A Fielding; D Kleinermans; N Buss
Journal:  Br J Clin Pharmacol       Date:  2000-08       Impact factor: 4.335

2.  Population pharmacokinetic model of the pregabalin-sildenafil interaction in rats: application of simulation to preclinical PK-PD study design.

Authors:  Gregor Bender; James Gosset; Jeff Florian; Keith Tan; Mark Field; Scott Marshall; Joost DeJongh; Robert Bies; Meindert Danhof
Journal:  Pharm Res       Date:  2009-08-11       Impact factor: 4.200

3.  Pharmacokinetics and tolerability of oral sildenafil in adults with cystic fibrosis lung disease.

Authors:  J L Taylor-Cousar; C Wiley; L A Felton; C St Clair; M Jones; D Curran-Everett; K Poch; D P Nichols; G M Solomon; M T Saavedra; F J Accurso; J A Nick
Journal:  J Cyst Fibros       Date:  2014-11-13       Impact factor: 5.482

4.  Comparative human pharmacokinetics and metabolism of single-dose oral and intravenous sildenafil.

Authors:  Gary J Muirhead; David J Rance; Donald K Walker; Philip Wastall
Journal:  Br J Clin Pharmacol       Date:  2002       Impact factor: 4.335

5.  The effects of age and renal and hepatic impairment on the pharmacokinetics of sildenafil.

Authors:  Gary J Muirhead; Keith Wilner; Wayne Colburn; Gertrude Haug-Pihale; Bernhard Rouviex
Journal:  Br J Clin Pharmacol       Date:  2002       Impact factor: 4.335

6.  The effects of steady-state erythromycin and azithromycin on the pharmacokinetics of sildenafil in healthy volunteers.

Authors:  Gary J Muirhead; Stephen Faulkner; Jane A Harness; Jörg Taubel
Journal:  Br J Clin Pharmacol       Date:  2002       Impact factor: 4.335

7.  The effects of sildenafil on human sperm function in healthy volunteers.

Authors:  Ken Purvis; Gary J Muirhead; Jane A Harness
Journal:  Br J Clin Pharmacol       Date:  2002       Impact factor: 4.335

8.  Pharmacokinetics of sildenafil after single oral doses in healthy male subjects: absolute bioavailability, food effects and dose proportionality.

Authors:  Donald J Nichols; Gary J Muirhead; Jane A Harness
Journal:  Br J Clin Pharmacol       Date:  2002       Impact factor: 4.335

9.  Sildenafil does not influence hepatic venous pressure gradient in patients with cirrhosis.

Authors:  Jens-Otto Clemmesen; Annamaria Giraldi; Peter Ott; Kim Dalhoff; Bent-Adel Hansen; Fin-Stolze Larsen
Journal:  World J Gastroenterol       Date:  2008-10-28       Impact factor: 5.742

10.  Development and validation of RP-HPLC method for sildenafil citrate in rat plasma-application to pharmacokinetic studies.

Authors:  A S Tripathi; I Sheikh; A P Dewani; P G Shelke; R L Bakal; A V Chandewar; P M Mazumder
Journal:  Saudi Pharm J       Date:  2012-10-13       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.